Long-Acting Injectable Antipsychotics: An Underutilized Treatment Option

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.In this issue, Kane and colleagues report on the efficacy of aripiprazole long-acting injection (LAI) in the treatment of an acute episode of schizophrenia. At 10 weeks of treatment, both psychopathology and functioning were improved in patients treated with aripiprazole compared to placebo, with an acceptable tolerability and safety profile. The outcomes suggest that aripiprazole long-acting is a viable treatment option for patients experiencing an acute episode of schizophrenia.